Legal
Negative
Replimune (REPL) Faces Securities Class Action Following Stock’s Collapse Amid FDA’s Rejection of Melanoma Drug – Hagens Berman
Breaking news from global financial markets
2 months ago
Read More
2 months ago
2,861
2 months ago
4,879
2 months ago
3,838
2 months ago
1,697
2 months ago
1,988
2 months ago
536
2 months ago
757
2 months ago
4,667
2 months ago
1,508
2 months ago
3,415
2 months ago
4,344
INVESTOR ALERT: Investigation of Nutex Health Inc. (NUTX) Announced by Holzer & Holzer, LLC
Legal
2 months ago
3,959
2 months ago
4,647
2 months ago
3,089
Trending Now
1
Consumer Portfolio Services GAAP EPS of $0.20, revenue of $108.4M
27,551
50 minutes ago
2
SoftBank unloads entire stake in Nvidia for $5.8B
3,623
59 minutes ago
3
EUR/USD holds in range as US government reopening hopes lift mood
25,550
1 hour ago
4
5
NZD/USD hovers around 0.5640, downside likely on RBNZ rate cut bets
21,359
1 hour ago